N
EVMN

Nuveen’s Evommune Inc EVMN Stock Holding History

Nuveen’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Buy
+12,452
New +$282K ﹤0.01% 3020

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $1.02B AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Nuveen's EVMN Position: Q1 2026 in Review

Nuveen opened a new position in Evommune Inc (EVMN) in Q1 2026: 12,452 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #3020 among its holdings.

84 funds tracked by Wall St. Rank hold EVMN as of Q1 2026.

  • Nuveen held 12,452 shares of Evommune Inc worth $286K as of Q1 2026.
  • Evommune Inc was a new Nuveen position in Q1 2026.
  • Evommune Inc made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3020 holding.
  • 84 funds tracked by Wall St. Rank held Evommune Inc as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.